FOXM1 and ovarian cancer: FOXM1 overexpression has been observed in multiple human cancers, including breast adenocarcinoma [17, 18], ovarian cancer [19], prostate cancer [20], nasopharyngeal carcinoma [21], cervical cancer [22], head and neck squamous cell carcinoma [23] and many others.